Format

Send to

Choose Destination
Emerg Infect Dis. 2008 Nov;14(11):1756-8. doi: 10.3201/eid1411.080337.

Growth and geographic variation in hospitalizations with resistant infections, United States, 2000-2005.

Author information

1
EviMed Research Group, LLC, Goshen, Massachussetts 01032, USA. marya@evimedgroup.org

Abstract

From 2000 through 2005, hospitalizations with resistant infections (methicillin-resistant Staphylococcus aureus, Clostridium difficile-associated disease, vancomycin-resistant enterococcus, Pseudomonas aeruginosa, and Candida infection) nearly doubled, from 499,702 to 947,393. Regional variations noted in the aggregate and by individual infection may help clarify modifiable risk factors driving these infections.

PMID:
18976563
PMCID:
PMC2630735
DOI:
10.3201/eid1411.080337
[Indexed for MEDLINE]
Free PMC Article

Supplemental Content

Full text links

Icon for CDC-NCEZID Icon for PubMed Central
Loading ...
Support Center